[HTML][HTML] Antiplatelet therapy for acute respiratory distress syndrome

CM Chen, HC Lu, YT Tung, W Chen - Biomedicines, 2020 - mdpi.com
Acute respiratory distress syndrome (ARDS) is a common and devastating syndrome that
contributes to serious morbidities and mortality in critically ill patients. No known …

[HTML][HTML] Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: A systematic review and meta-analysis

D Mohananey, J Sethi, PA Villablanca… - Annals of cardiac …, 2016 - journals.lww.com
Aim: Platelet function is intricately linked to the pathophysiology of critical Illness, and some
studies have shown that antiplatelet therapy (APT) may decrease mortality and incidence of …

[HTML][HTML] Effect of antiplatelet therapy on acute respiratory distress syndrome and mortality in critically ill patients: a meta-analysis

L Wang, H Li, X Gu, Z Wang, S Liu, L Chen - PloS one, 2016 - journals.plos.org
Background Antiplatelet agents are commonly used for cardiovascular diseases, but their
pleiotropic effects in critically ill patients are controversial. We therefore performed a meta …

[HTML][HTML] The role of platelets in acute lung injury (ALI)

A Zarbock, K Ley - Frontiers in bioscience: a journal and virtual …, 2009 - ncbi.nlm.nih.gov
Acute lung injury (ALI) is a common syndrome associated with a high mortality rate. Better
understanding of the pathophysiology of acute lung injury and progress in supportive care …

Platelets in the pathogenesis of acute respiratory distress syndrome

H Yadav, DJ Kor - … Journal of Physiology-Lung Cellular and …, 2015 - journals.physiology.org
Platelets have an emerging and incompletely understood role in a myriad of host immune
responses, extending their role well beyond regulating thrombosis. Acute respiratory …

Early intravascular events are associated with development of acute respiratory distress syndrome. A substudy of the LIPS-A clinical trial

REE Abdulnour, T Gunderson, I Barkas… - American journal of …, 2018 - atsjournals.org
Rationale: Acute respiratory distress syndrome (ARDS) is a devastating illness with limited
therapeutic options. A better understanding of early biochemical and immunological events …

Beyond thrombosis: the versatile platelet in critical illness

JN Katz, KP Kolappa, RC Becker - Chest, 2011 - Elsevier
Sepsis, acute lung injury, and ARDS contribute substantially to the expanding burden of
critical illness within our ICUs. Each of these processes is characterized by a myriad of …

[HTML][HTML] Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome

P Toner, DF McAuley, M Shyamsundar - Critical care, 2015 - Springer
Sepsis is a common condition that is associated with significant morbidity, mortality and
health-care cost. Pulmonary and non-pulmonary sepsis are common causes of the acute …

Prevention or treatment of ARDS with aspirin: a review of preclinical models and meta-analysis of clinical studies

BA Panka, HJ de Grooth, AME Spoelstra-de Man… - Shock, 2017 - journals.lww.com
Background: The acute respiratory distress syndrome (ARDS) is a life-threating disorder that
contributes significantly to critical illness. No specific pharmacological interventions directed …

Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study

JM Erlich, DS Talmor, R Cartin-Ceba, O Gajic, DJ Kor - Chest, 2011 - Elsevier
Background Acute lung injury (ALI) is a potentially fatal lung disease with few treatment
options. Platelet activation is a key component of ALI pathophysiology and may provide an …